FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Watch Fox News’ Martha MacCallum Grill Dem Who Told Military to Defy Trump

Five Billion Dollars Off: California Officials Admit They Botched Deficit Estimate By Billions

Trump says Dems who told military to defy illegal orders committed ‘sedition at the highest level’

Texas National Guard to return from Illinois ahead of Thanksgiving, Gov Abbott says

Texas A&M committee finds professor’s firing over transgender-related lesson unjustified

Man fatally shot, woman and children in critical condition after Arizona shootout

President says Chicagoans are ‘chanting bring in Trump’ after violent downtown riot leaves 8 shot, 1 dead

JFK’s granddaughter, Tatiana Schlossberg, reveals terminal cancer diagnosis in heartbreaking essay

Op-Ed: The Aftermath of No Kings and the Warning it Sends to Us All

Fact Check: Has the Coast Guard OK’d Swastikas, Other Hate Symbols Under Hegseth Changes?

Explosion rocks senior living apartment building in Ohio, multiple people injured

Trump Terminates Immigrant TPS Status in Minnesota to Destroy ‘Hub of… Money Laundering’ Under Governor Walz

‘Marjorie Traitor Brown’: Trump Responds to MTG’s Resignation

Israel launches attack in Gaza that Hamas says could mean ‘collapse’ of ceasefire

Chicago train fire attack shows why ‘decarceration’ policies are putting lives at risk: expert

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”